{"nct_id":"NCT05631093","title":"A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2023-02-20","start_date_type":"ACTUAL","primary_completion_date":"2024-10-10","primary_completion_date_type":"ACTUAL","completion_date":"2028-07-11","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}